153 related articles for article (PubMed ID: 35850446)
1. Recent advances in the development of transplanted colorectal cancer mouse models.
Yang YS; Liu CY; Wen D; Gao DZ; Lin S; He HF; Zhao XF
Transl Res; 2022 Nov; 249():128-143. PubMed ID: 35850446
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of colorectal cancer: Past, present and future perspectives.
Bürtin F; Mullins CS; Linnebacher M
World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.
Rizzo G; Bertotti A; Leto SM; Vetrano S
J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma.
Yakou MH; Afshar-Sterle S; Ernst M; Mielke LA
Methods Mol Biol; 2024; 2806():197-207. PubMed ID: 38676804
[TBL] [Abstract][Full Text] [Related]
5. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer murine models: Initiation to metastasis.
Pothuraju R; Khan I; Jain M; Bouvet M; Malafa M; Roy HK; Kumar S; Batra SK
Cancer Lett; 2024 Apr; 587():216704. PubMed ID: 38360138
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
8. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
10. Experimental Murine Models for Colorectal Cancer Research.
Neto Í; Rocha J; Gaspar MM; Reis CP
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174036
[TBL] [Abstract][Full Text] [Related]
11. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
Roper J; Hung KE
Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
[TBL] [Abstract][Full Text] [Related]
12. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
Front Immunol; 2020; 11():614300. PubMed ID: 33643296
[TBL] [Abstract][Full Text] [Related]
13. Advanced Colorectal Cancer Orthotopic Patient-Derived Xenograft Models for Cancer and Stem Cell Research.
Chicote I; Cámara JA; Palmer HG
Methods Mol Biol; 2020; 2171():321-329. PubMed ID: 32705653
[TBL] [Abstract][Full Text] [Related]
14. Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
Yorita N; Yuge R; Takigawa H; Ono A; Kuwai T; Kuraoka K; Kitadai Y; Tanaka S; Chayama K
Cancer Lett; 2021 Feb; 498():111-120. PubMed ID: 33129954
[TBL] [Abstract][Full Text] [Related]
15. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
[TBL] [Abstract][Full Text] [Related]
17. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
18. The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.
Zafari N; Khosravi F; Rezaee Z; Esfandyari S; Bahiraei M; Bahramy A; Ferns GA; Avan A
J Clin Lab Anal; 2022 Aug; 36(8):e24585. PubMed ID: 35808903
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer.
Chicote I; Martínez-Quintanilla J; Cámara JA; Palmer HG
J Vis Exp; 2023 Feb; (192):. PubMed ID: 36847362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
